Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brensocatib in Chronic Rhinosinusitis Without Nasal Polyps (BiRCh)
NCT06013241Phase 2Completed
- Sponsor
- Insmed Incorporated
- Start
- Oct 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of brensocatib in chronic rhinosinusitis without nasal polyps (CRSsNP), sponsored by Insmed Incorporated. Started Oct 2023; status: completed.
02
Drugs
brensocatib
03
Conditions
chronic rhinosinusitis without nasal polyps (CRSsNP)
Beyond the preview
Go deeper on NCT06013241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06013241.